Covid-19 Update

James Davies Excerpts

Tuesday 2nd February 2021 Commons Chamber

[Matt Hancock]

I am very happy for either me or one of my team to meet the hon. Lady to discuss this issue and make sure that it is looked into properly.

[Dr James Davies (Vale of Clwyd) (Con) [V]]

The development, production and roll-out of vaccines in Britain is increasingly envied across the world, and the Wockhardt factory in north Wales is playing its part in that process. What plans does my right hon. Friend have to increase the production of vaccines in the UK further, both to meet our own needs and to allow us to assist our friends in the Republic of Ireland and elsewhere?

[Matt Hancock]

The onshoring of vaccine manufacturing is an incredibly important part of our strategy. We were previously very, very good at the research and at the regulation of vaccines, but onshore manufacturing was sparse. We have built that manufacturing capability, including at Wockhardt on the Wrexham industrial estate, as my hon. Friend mentioned, and also now with production in Scotland, Teesside and elsewhere, with more to come. It is a strategic choice that this country should make that we should bring onshore the manufacturing in critical industries and of critical products such as vaccines, not least because there is not going to be a global glut of vaccine manufacturing capability for a long time to come. We are at the forefront of the science, and we should be at the forefront of the manufacturing and production.